Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category (Ascending) Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
67457-0493-46 67457-0493 Carboplatin Carboplatin 10.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Nov. 9, 2011 Dec. 31, 2017 No Longer Used
67457-0494-61 67457-0494 Carboplatin Carboplatin 10.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Nov. 9, 2011 Dec. 31, 2017 No Longer Used
67457-0608-20 67457-0608 Carboplatin Carboplatin 10.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Nov. 9, 2011 Dec. 31, 2017 No Longer Used
67457-0424-10 67457-0424 Cisplatin Cisplatin 1.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous April 19, 2012 Dec. 31, 2017 No Longer Used
67457-0425-51 67457-0425 Cisplatin Cisplatin 1.0 mg/mL Chemotherapy Alkylating Agent Platinum Compound Intravenous April 19, 2012 Dec. 31, 2017 No Longer Used
58468-0100-01 58468-0100 Clofarabine Clolar 1.0 mg/mL Chemotherapy Antimetabolite Purine Analog Intravenous Dec. 28, 2004 March 31, 2013 No Longer Used
58468-0100-02 58468-0100 Clofarabine Clolar 1.0 mg/mL Chemotherapy Antimetabolite Purine Analog Intravenous Dec. 28, 2004 March 31, 2013 No Longer Used
00078-0681-66 00078-0681 Dabrafenib Tafinlar 75.0 mg/1 Chemotherapy Enzyme Inhibitor BRAF Oral April 1, 2016 In Use
00078-0682-66 00078-0682 Dabrafenib Tafinlar 50.0 mg/1 Chemotherapy Enzyme Inhibitor BRAF Oral April 12, 2016 In Use
00069-0170-01 00069-0170 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Oct. 29, 2011 Dec. 31, 2017 No Longer Used
00069-0171-01 00069-0171 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Oct. 29, 2011 Dec. 31, 2017 No Longer Used
00069-3030-20 00069-3030 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Dec. 23, 1987 In Use
00069-3034-20 00069-3034 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Dec. 23, 1987 In Use
67457-0394-00 67457-0394 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 20.0 mg/10mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Feb. 14, 2012 April 30, 2016 No Longer Used
67457-0394-10 67457-0394 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 20.0 mg/10mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Feb. 14, 2012 April 30, 2013 No Longer Used
00069-0174-01 00069-0174 Fluorouracil Fluorouracil 50.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous July 18, 2012 Nov. 30, 2014 No Longer Used
00069-0176-01 00069-0176 Fluorouracil Fluorouracil 50.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous July 18, 2012 Nov. 30, 2014 No Longer Used
00310-0482-30 00310-0482 Gefitinib IRESSA 250.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor EGFR Oral July 13, 2015 In Use
00310-0482-93 00310-0482 Gefitinib IRESSA 250.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor EGFR Oral July 25, 2016 Aug. 31, 2019 In Use
00409-0181-01 00409-0181 GEMCITABINE Gemcitabine 38.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Aug. 26, 2011 In Use
00409-0181-25 00409-0181 GEMCITABINE Gemcitabine 38.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous July 9, 2013 In Use
00409-0182-01 00409-0182 GEMCITABINE Gemcitabine 38.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Aug. 22, 2011 In Use
00409-0182-25 00409-0182 GEMCITABINE Gemcitabine 38.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous July 29, 2013 In Use
00409-0183-01 00409-0183 GEMCITABINE Gemcitabine 38.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Aug. 24, 2011 In Use
00409-0183-25 00409-0183 GEMCITABINE Gemcitabine 38.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous July 9, 2013 In Use

Found 10,000 results in 5 milliseconds — Export these results